Cure My Disease

Don't miss your cure!

 Log in / Sign up

Major trial tests promising new obesity drug in japan

NCT ID NCT06987695

Ongoing Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new injectable medicine called maridebart cafraglutide helps adults in Japan lose weight and improve their health better than a placebo (dummy treatment). It involves 279 adults with obesity and related health conditions like high blood pressure or type 2 diabetes. Participants receive the drug or placebo for 72 weeks while researchers measure changes in body weight, waist size, cholesterol, and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Adachi Kyosai Hospital

    Adachi-ku, Tokyo, 120-0022, Japan

  • Aira Diabetes Thyroid Internal Medicine Clinic

    Aira-shi, Kagoshima-ken, 899-5421, Japan

  • Deguchi Clinic

    Kobe, Hyōgo, 652-0803, Japan

  • Fukuoka Shinmizumaki Hospital

    Onga-gun, Fukuoka, 807-0051, Japan

  • Hosokawa Surgical Clinic

    Nagoya, Aichi-ken, 453-0812, Japan

  • Ikebukuro Metropolitan Clinic

    Toshima-ku, Tokyo, 171-0021, Japan

  • Joh Medical Clinic

    Osaka, Osaka, 530-0002, Japan

  • Kobe University Hospital

    Kobe, Hyōgo, 650-0017, Japan

  • Kyoto University Hospital

    Kyoto, Kyoto, 606-8507, Japan

  • Kyushu University Hospital

    Fukuoka, Fukuoka, 812-8582, Japan

  • MIH Clinic Yoyogi

    Shibuya-ku, Tokyo, 151-0051, Japan

  • Manda Memorial Hospital

    Sapporo, Hokkaido, 060-0062, Japan

  • Matsuba Clinic

    Kawasaki-shi, Kanagawa, 212-0024, Japan

  • Matsunami Health Promotion Clinic

    Hashima-gun, Gifu, 501-6061, Japan

  • Medical Corporation Boocs Boocs Clinic Fukuoka

    Fukuoka, Fukuoka, 812-0025, Japan

  • Medical Corporation Chiseikai Tokyo Center Clinic

    Chuo-ku, Tokyo, 103-0027, Japan

  • Medical Corporation Keiseikai Kajiyama Clinic

    Kyoto, Kyoto, 600-8898, Japan

  • Medical Corporation Kenshinkai Minamino Cardiovascular Hospital

    Hachioji-shi, Tokyo, 192-0918, Japan

  • Meitetsu Hospital

    Nagoya, Aichi-ken, 451-8511, Japan

  • Midori Clinic

    Nagasaki, Nagasaki, 852-8034, Japan

  • Nihonbashi Sakura Clinic

    Chuo-ku, Tokyo, 103-0025, Japan

  • Nishiyamado Keiwa Hospital

    Naka, Ibaraki, 311-0133, Japan

  • Shimamura Memorial Hospital

    Nerima-ku, Tokyo, 177-0051, Japan

  • Shinjuku Southern Clinic

    Shinjuku-ku, Tokyo, 160-0023, Japan

  • Social Medical Corporation Kojunkai Daido Clinic

    Nagoya, Aichi-ken, 457-8511, Japan

  • Tashiro Endocrinology Clinic

    Fukuoka, Fukuoka, 814-0153, Japan

  • Tokyo Saiseikai Central Hospital

    Minato-ku, Tokyo, 108-0073, Japan

  • Urasoe General Hospital

    Urasoe-shi, Okinawa, 901-2102, Japan

  • Wellness Tenjin Clinic

    Fukuoka, Fukuoka, 810-0001, Japan

  • Yamasaki Family Clinic

    Amagasaki-shi, Hyōgo, 660-0861, Japan

Conditions

Explore the condition pages connected to this study.

OBESITY DISEASE